Brief: Sprint Bioscience starts diabetes program

Sprint Bioscience AB

30/11/2015 07:33

Nov 30 (Reuters) - Sprint Bioscience AB  SPRINT.ST : 
    * Has entered into cooperation with Lundberglaboratoriet för Diabetesforskning (Lundberg 
Laboratory for Diabetes Research) at Gothenburg University where the company is to develop drug 
candidates against new target protein that is central to development of type 2 diabetes 
    * The aim is to start the process of licensing the project in 2016 
 
     
Source text for Eikon:  ID:nWkrkC5529  
     
Further company coverage:  SPRINT.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))